(redirected from Lysosomal Acid Lipase)
Also found in: Dictionary, Medical, Financial.
LIPALong Island Power Authority
LIPALiverpool Institute of Performing Arts (UK)
LIPALocal Internet Protocol Access
LIPALysosomal Acid Lipase (deficiency)
LIPALane Individual Practice Association (est. 1976; Eugene, OR)
LIPALane Independent Provider Association
LIPALabor Institute of Public Affairs (est. 1982)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.
We report the case of two siblings with LAL-D and with compound heterozygous mutations in the lysosomal acid lipase A (LIPA) gene.
[3] Nonstandard abbreviations: LAL, lysosomal acid lipase; DBS, dried blood spot on a newbornscreening card; P-PMHC, 4-propyl-8-methyl-7-hydroxycoumarin.
Abbreviations BMI: Body mass index HDL-C: High-density lipoprotein cholesterol LAL: Lysosomal acid lipase LDL-C: Low-density lipoprotein cholesterol LIPA: Lysosomal acid lipase gene PAS: Periodic acid-Schiff DBS: Dried Blood Spots.
Reiner Z, Guardamagna O, Nair D et al Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.
Maciejko, "Managing cardiovascular risk in lysosomal acid lipase deficiency," American Journal of Cardiovascular Drugs, vol.
The remaining 38 agents can be classified into the following categories: anticoagulant (2), antidiarrheal (1), antidiabetic (1), antidote (3), antiemetic (1), antifungal (1), antilipemic (2), antineoplastic (13), antipsychotic (2), antiviral (1), bile acid (2), cardiovascular (2), female sexual dysfunction (1), immunomodulator (1), lysosomal acid lipase deficiency (1), parathyroid hormone (1), pyrimidine analog (1), and respiratory (2).
London, United Kingdom, April 20, 2016 --(, the website for healthcare professionals, has today announced the launch of a new educational resource for lysosomal acid lipase (LAL) deficiency.
Patients with Wolman disease have lysosomal acid lipase deficiency (LAL-D), which results in a fat buildup within the cells of various tissues.
(1992) reported the structure and evolution of lipse superfamily.Crystal structure of human gastric lipase and model of lysosomal acid lipase, two lipolytic enzymes of medical interest was reported by (Roussel et al., 1999).
The company's lead programme is SBC-102, which is a recombinant form of the human LAL enzyme being developed as an enzyme replacement therapy for Lysosomal Acid Lipase Deficiency, a lysosomal storage disorder.
Full browser ?